Nicholas Bertos
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- Histone Deacetylase Inhibitors Research 10
- Epigenetics and DNA Methylation 6
- RNA modifications and cancer 6
- Ubiquitin and proteasome pathways 5
- Oncology 16
- Cancer Cells and Metastasis 9
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Morag Park (28 shared papers)Michael Hallett (12 shared papers)Atilla Ömeroğlu (9 shared papers)Xiang‐Jiao Yang (8 shared papers)Margarita Souleimanova (6 shared papers)François Pépin (3 shared papers)Sarkis Meterissian (5 shared papers)Greg Finak (3 shared papers)
- Journals
- Cancer Research (7 papers)Journal of Biological Chemistry (6 papers)Molecular and Cellular Biology (3 papers)Clinical Cancer Research (3 papers)Biochemistry and Cell Biology (2 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Nicholas Bertos
56 papers receiving 4.4k citations
Nicholas Bertos's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 886
- Oncology 1.3k
- Molecular Biology 2.8k
- Immunology 574
- Immunology and Allergy 117
Countries citing papers authored by Nicholas Bertos
This map shows the geographic impact of Nicholas Bertos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Bertos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Bertos more than expected).
Fields of papers citing papers by Nicholas Bertos
This network shows the impact of papers produced by Nicholas Bertos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Bertos. The network helps show where Nicholas Bertos may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicholas Bertos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stromal gene expression predicts clinical outcome in breast cancer Hit paper breakdown → | 2008 | 1291 |
| 2 | 1999 | 252 | |
| 3 | 2010 | 235 | |
| 4 | 2000 | 233 | |
| 5 | 2001 | 225 | |
| 6 | 2019 | 204 | |
| 7 | 2003 | 202 | |
| 8 | 2001 | 184 | |
| 9 | 2011 | 168 | |
| 10 | 2001 | 160 | |
| 11 | 2010 | 157 | |
| 12 | 1999 | 128 | |
| 13 | 2004 | 128 | |
| 14 | 2010 | 116 | |
| 15 | 2011 | 72 | |
| 16 | 2018 | 66 | |
| 17 | 2017 | 61 | |
| 18 | 2014 | 54 | |
| 19 | 2015 | 47 | |
| 20 | 2012 | 44 |
About Nicholas Bertos
Nicholas Bertos is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Surgery, having authored 57 papers that have together received 4.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (10 papers), Cancer Cells and Metastasis (9 papers), Epigenetics and DNA Methylation (6 papers), Cancer Genomics and Diagnostics (6 papers), RNA modifications and cancer (6 papers), Ubiquitin and proteasome pathways (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cancer Research (886 citations), Oncology (1.3k citations), Molecular Biology (2.8k citations), Immunology (574 citations) and Immunology and Allergy (117 citations). Nicholas Bertos has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Morag Park, Michael Hallett, Atilla Ömeroğlu, Xiang‐Jiao Yang, Margarita Souleimanova, François Pépin, Sarkis Meterissian, Greg Finak, Svetlana Sadekova and Hong Zhao. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Molecular and Cellular Biology, Clinical Cancer Research and Biochemistry and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.